Breast cancer screening: Medicare qualified entity public report

In 2025, it is projected that over 315,000 new cases of breast cancer will be diagnosed.

Given the relative prevalence of this disease, breast cancer screening is common and recommended for all women and assigned female at birth persons over a certain age and with various risk factors.

In this report, we assess breast cancer screening recall rates as measured by CMS and determine ranges for Medicare beneficiaries, commercial beneficiaries, and an aggregate across Medicare and commercial beneficiaries.

Download our report to learn how breast cancer screening recall rates vary across markets and payor types.